By Blake Brittain (Reuters) – Biotech company Alnylam Pharmaceuticals Inc filed new lawsuits on Friday against Pfizer Inc and Moderna Inc in Delaware federal court, again claiming that the companies’…
By Blake Brittain (Reuters) – Despite the backing of the U.S. government, Moderna Inc on Friday failed to persuade a federal judge it should not have to face a patent…
(Reuters) – Moderna Inc will make certain contingent development, commercial and regulatory milestone payments to the U.S. National Institutes of Health (NIH) related to the development of COVID-19 vaccines, the…
(Reuters) – Moderna Inc said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022. (Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
Moderna Suing Pfizer For COVID-19 Vaccine Patent Infringement Trevor Schakohl on August 26, 2022 Moderna is filing patent infringement lawsuits against Pfizer and BioNTech in U.S. district court and German…
LONDON – Moderna’s COVID-19 variant vaccine will be ready to ship in August as the company has been making shots ahead of approval, Chief Executive Stephane Bancel told Reuters on…
(Reuters) – U.S. Food and Drug Administration advisers on Wednesday recommended the authorization of Moderna Inc’s COVID-19 vaccine for children aged 6 months through 5 years, an important step toward…
MADRID – Moderna plans to invest around 500 million euros ($520.60 million) in a new laboratory in Spain to boost its production of vaccines, Spanish Prime Minister Pedro Sanchez said…
WASHINGTON -The U.S. Food and Drug Administration set June 14-15 as the new meeting date to review Moderna Inc’s emergency authorization request for its COVID-19 vaccine for children aged 6…
(Reuters) – Moderna Inc on Monday named Jorge Gomez, a senior executive at dental products maker Dentsply Sirona Inc, as its new chief financial officer, effective May 9. Gomez, who…
– Moderna Inc on Thursday raised its full-year forecast for sales of its COVID-19 vaccine to roughly $21 billion from $19 billion. The company in February forecast sales of $19…
– Moderna Inc said on Friday it is developing three new vaccines based on the same technology used for its COVID-19 shot, including one for viral infection shingles. The success…
(This Feb. 16 story has been corrected to show price to be very similar to high-dose flu vaccine, not COVID vaccine, in paragraph 8) By Francesco Guarascio BRUSSELS – An…
Moderna Inc said on Wednesday it had started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically designed to target the Omicron coronavirus variant, a day after…
By Nancy Lapid – The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet…
Guess what? If you’ve been fully vaccinated and boosted with Moderna’s mRNA COVID-19 vaccine, you’re not done yet, according to company CEO Stephane Bancel. Bancel announced this week that those…
Trevor Noah, host of Comedy Central’s “The Daily Show” has raised more than a few eyebrows after slamming Moderna CEO Stephane Bancel, claiming Bancel is pushing COVID-19 vaccines simply to…
Moderna is in the early stages of developing a single-dose vaccine that protects against both the flu and COVID-19, the company announced Thursday. “Today we are announcing the first step…
The pandemic goal line has just been moved again as Dr. Anthony Fauci announced Americans will need annual COVID-19 booster shots. Fauci this week said COVID-19 vaccines for some may…